Transcriptomics

Dataset Information

0

Epigenetic silencing of Th1 chemokines shapes tumor immunity, immunotherapy and patient outcome [GSK126]

ABSTRACT: To define the gene profile altered by EZH2 and H3K27me3 in response to IFNg, we performed several microarrays in primary ovarian cancer cells transfected with shEZH2 or treated with GSK126. We found that 155 and 124 genes were altered by shEZH2 and GSK126 treatment, respectively, and 20 genes were increased or decreased by both shEZH2 and GSK126 treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE71869 | GEO | 2015/08/11

SECONDARY ACCESSION(S): PRJNA292384

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Epigenetic silencing of Th1 chemokines shapes tumor immunity, immunotherapy and patient outcome [GSK126]
2015-08-11 | E-GEOD-71869 | biostudies-arrayexpress
Transcriptomics Epigenetic silencing of Th1 chemokines shapes tumor immunity, immunotherapy and patient outcome [shEZH2]
2015-08-11 | GSE71870 | GEO
Transcriptomics Epigenetic silencing of Th1 chemokines shapes tumor immunity, immunotherapy and patient outcome [shEZH2]
2015-08-11 | E-GEOD-71870 | biostudies-arrayexpress
Transcriptomics Epigenetic silencing of Th1 chemokines shapes tumor immunity, immunotherapy and patient outcome
2015-08-11 | E-GEOD-71871 | biostudies-arrayexpress
Transcriptomics Epigenetic silencing of Th1 chemokines shapes tumor immunity, immunotherapy and patient outcome
2015-08-11 | GSE71871 | GEO
Unknown Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.
| S-EPMC4779053 | biostudies-literature
Transcriptomics Expression analysis after co-treatment of GSK126 and pomalidomide
2020-09-23 | GSE147320 | GEO
Transcriptomics BMP2 and GSK126 synergize to induce expression of osteogenic genes
2019-12-01 | GSE135984 | GEO
Genomics Expression analysis after co-treatment of GSK126 and pomalidomide
| PRJNA613728 | ENA
Transcriptomics Transcriptomic profiling of MGT#1-mVenus-reporter harboring A549 and H1944 cells upon stimulation with GSK126 and TGF-β1.
2023-08-20 | GSE240898 | GEO